Date	Period	Revenue/Estimate	Earnings Call
May 8, 2025	2025/Q4	-- / 3.112B	--
Jan 31, 2025	2025/Q3	2.436B / 2.550B	--
Oct 31, 2024	2025/Q2	2.604B / 2.800B	--
Jul 31, 2024	2025/Q1	2.234B / 2.400B	--
May 8, 2024	2024/Q4	3.190B / 3.079B	--

DatePeriodRevenue/EstimateEarnings Call

May 8, 20252025/Q4-- / 3.112B--

Jan 31, 20252025/Q32.436B / 2.550B--

Oct 31, 20242025/Q22.604B / 2.800B--

Jul 31, 20242025/Q12.234B / 2.400B--

May 8, 20242024/Q43.190B / 3.079B--

Unlock Free Earnings Estimates

Open Account

Digital Arts Earnings Reports

Digital Arts: Summary of Financial Results for the 3rd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)

Jan 31 02:00 ET

Digital Arts: Confirmation letter

Nov 8, 2024 01:06 ET

Digital Arts: Half Year Report - Term 30 (2024/04/01 - 2025/03/31)

Nov 8, 2024 01:03 ET

Digital Arts: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (Consolidated)

Oct 31, 2024 03:00 ET

Symbol Price % Chg

Kyorin Pharmaceutical

4569

1677 +21.79%